MN-166 Presentation | MediciNova, Inc.

2023.11.01 MN-166(ibudilast) for Glioblastoma : Society for Neuro-Oncology (SNO) 2023 Poster

2021.12.01 MN-166(ibudilast)for ALS : International Symposium on ALS-MND 2021 Poster

2021.08.23 MN-166(ibudilast) ALS Webinar

2019.12.01 MN-166(ibudilast)for ALS : International Symposium on ALS-MND 2019 Poster

2019.05.02 MN-166(ibudilast) for Progressive MS : SPRINT-MS Phase 2b Trial AAN 2019 Poster-OCT-Macular Measures

2019.05.01 MN-166(ibudilast) for Progressive MS : SPRINT-MS Phase 2b Trial AAN 2019 Poster-NfL

2018.12.01 MN-166(ibudilast)for ALS : International Symposium on ALS-MND 2018 Presentation

2018.07.01 MN-166(ibudilast) for Progressive MS : SPRINT-MS Phase 2b Trial Disability Date ACTRIMS 2018 Poster

2018.04.03 MN-166(ibudilast) for Progressive MS : SPRINT-MS Phase 2b Trial AAN 2018 Presentation

2018.04.02 MN-166(ibudilast) for ALS : American Academy of Neurology (AAN) 2018 Poster

2018.04.01 MN-166(ibudilast) for ALS : International Symposium on ALS-MND 2017 Presentation

2017.07.05 MN-166(ibudilast) for Progressive MS : SPRINT-MS Phase 2b Trial Top-Line Results ECTRIMS 2017 Presentation

2017.07.04 MN-166(ibudilast) for Glioblastoma : American Society of Clinical Oncology (ASCO) 2017 Poster

2017.07.03 MN-166(ibudilast) for Opioid Dependence : American Academy of Neurology (AAN) Poster

2017.07.02 MN-166(ibudilast) for Methamphetamine Dependence : College of Problems of Drug Dependence (CPDD) Poster

2017.07.01 MN-166(ibudilast) for Alcohol Dependence : American College of Neuropsychopharmacology (ACNP) Poster

2015.07.01 MN-166(ibudilast) for Progressive MS : American Academy of Neurology (AAN) 2015 Poster

MN-166 Presentation Search results